D. M. V. van Rijswijck

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

A. Heck, R. Sanders, M. V. van Gils, 2022, Nature Communications.

No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients

M. V. van Gils, J. Snijder, S. Spadaro, 2022, medRxiv.

Affimers as an alternative to antibodies for protein biomarker enrichment.

Hans J C T Wessels, C. Tack, R. Hannam, 2020, Protein expression and purification.

IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants

A. Heck, R. Sanders, M. V. van Gils, 2022, bioRxiv.

Into the Dark Serum Proteome: Personalized Features of IgG1 and IgA1 Repertoires in Severe COVID-19 Patients

J. Snijder, M. V. van Gils, M. Contoli, 2023, Molecular & cellular proteomics : MCP.

Human plasma IgG1 repertoires are simple, unique, and dynamic

J. Snijder, O. Cremer, A. Bondt, 2021, Cell systems.

A Direct MS-Based Approach to Profile Human Milk Secretory Immunoglobulin A (IgA1) Reveals Donor-Specific Clonal Repertoires With High Longitudinal Stability

A. Heck, A. Bondt, K. Dingess, 2021, Frontiers in Immunology.